Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: Two-Year Results of the Real Word Evidence LIBRA Study.

Erdes SF, Mazurov VI, Gaidukova IZ, Anoshenkova ON, Vinogradova IB, Grabovetskaya YY, Davidian SY, Epifanova OE, Kiryukhina NA, Masneva LV, Menshikova IV, Mironenko ON, Nikulenkova NE, Povarova TV, Polyatika AN, Samigullina RR, Sizikov AE, Totrov IN, Umnova IF, Chudinov AL

Open source

DOI: 10.1134/s1607672925700279
Published: 2026 Feb
Container: Doklady. Biochemistry and biophysics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1134/s1607672925700279,
  title = {Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: Two-Year Results of the Real Word Evidence LIBRA Study.},
  author = {Erdes SF and Mazurov VI and Gaidukova IZ and Anoshenkova ON and Vinogradova IB and Grabovetskaya YY and Davidian SY and Epifanova OE and Kiryukhina NA and Masneva LV and Menshikova IV and Mironenko ON and Nikulenkova NE and Povarova TV and Polyatika AN and Samigullina RR and Sizikov AE and Totrov IN and Umnova IF and Chudinov AL},
  year = {2026},
  journal = {Doklady. Biochemistry and biophysics},
  doi = {10.1134/s1607672925700279},
  url = {https://doi.org/10.1134/s1607672925700279}
}

RIS

TY  - JOUR
TI  - Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: Two-Year Results of the Real Word Evidence LIBRA Study.
AU  - Erdes SF
AU  - Mazurov VI
AU  - Gaidukova IZ
AU  - Anoshenkova ON
AU  - Vinogradova IB
AU  - Grabovetskaya YY
AU  - Davidian SY
AU  - Epifanova OE
AU  - Kiryukhina NA
AU  - Masneva LV
AU  - Menshikova IV
AU  - Mironenko ON
AU  - Nikulenkova NE
AU  - Povarova TV
AU  - Polyatika AN
AU  - Samigullina RR
AU  - Sizikov AE
AU  - Totrov IN
AU  - Umnova IF
AU  - Chudinov AL
PY  - 2026
JO  - Doklady. Biochemistry and biophysics
DO  - 10.1134/s1607672925700279
UR  - https://doi.org/10.1134/s1607672925700279
ER  -

APA

SF, E., VI, M., IZ, G., ON, A., IB, V., YY, G., SY, D., OE, E., NA, K., LV, M., IV, M., ON, M., NE, N., TV, P., AN, P., RR, S., AE, S., IN, T., IF, U., & AL, C. (2026). Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: Two-Year Results of the Real Word Evidence LIBRA Study.. Doklady. Biochemistry and biophysics. https://doi.org/10.1134/s1607672925700279

Source records

pubmed · retrieved 2026-09-26T07:55:34.172Z